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Abstract
A glutamine for proline substitution at position 1098 was previously shown to result in accumulation of brush-border
sucrase–isomaltase in the Golgi apparatus. The substitution is present in a highly homologous region of the protein, and
results in a comparable accumulation when introduced into the same region in lysosomal a-glucosidase. To study the
importance of the glutamine-1098, we analyzed the transport compatibility of two mutants in which glutamine-1098 is
substituted by lysine or alanine. Both mutants were transported to the cell surface and processed comparable to wild type.
We concluded that glutamine-1098 is not essential for transport to the cell surface. q 1998 Elsevier Science B.V. All rights
reserved.
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1. Introduction
 .Sucrase–isomaltase SI is a type II transmem-
brane glycoprotein that is expressed at the brush-
border of intestinal epithelial cells, where it is respon-
sible for the degradation of sugar and some products
w xof starch digestion 1,2 . After synthesis in the ER
Abbreviations: SI: sucrase–isomaltase; CSID: congenital su-
crase–isomaltase deficiency; Q1098P, Q1098A, Q1098K,
Q1098X: glutamine at position 1098, substituted for proline,
 .alanine, lysine and any amino acid resp.
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and processing in the Golgi apparatus, SI is directly
w xtransported to the apical membrane 3 . Along this
pathway, there are several general checkpoints that
regulate transport of only properly folded proteins
w x4,5 . The most prominent checkpoint is situated in
the ER, where several chaperones cooperate with
modification enzymes such as protein disulfide iso-
merase and glycosyl transferases to generate properly
w xfolded molecules 6–9 . Improperly folded molecules
are retained until they have acquired a proper folding
or they are degraded in a proteasome-dependent fash-
w xion 10 . There are some proteins however, that are
not folded properly, but still exit the ER. For in-
stance, in some phenotypes of congenital sucrase–
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 .isomaltase deficiency CSID , SI is transported out of
w xthe ER but is retained in the Golgi apparatus 11,12 .
These phenotypes are a useful candidate to study
quality control mechanisms beyond the ER.
Previously, we reported the identification of a
point mutation in the cDNA from a CSID patient that
is responsible for the accumulation of the molecule in
w xthe Golgi apparatus 13,14 . The mutation results in a
substitution of a glutamine for a proline at position
 .1098 in the amino acid sequence Q1098P . This
mutation is localized in a region that is highly homol-
ogous between several proteins of the family of
 . w xglycosyl hydrolases Fig. 1 15 . Substitution of the
glutamine residue for proline at the corresponding
Fig. 1. Alignment of 10 parts of amino acid sequences of related proteins. All proteins are a-glucosidases, and possess the consensus
sequence of the family of glycosyl hydrolases. The amino acids that are 100% homologous are marked by a grey box, the 16 amino acids
with 90% homology by a white box. The position of Q1098 in human SI is indicated below the sequence.
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position of another member of the family, human
lysosomal a-glucosidase, resulted in a comparable
w xaccumulation 14 .
What exactly causes the accumulation remains to
be established. It could be that the glutamine residue
in the conserved region is important for proper trans-
port of the proteins along the secretory pathway. In
this case, introduction of other amino acids at the
same position would lead to transport defects as well.
Alternatively, the introduction of the proline residue
into the polypeptide could have lead to such alter-
ations in the folding of the molecule, that it is
recognized by some kind of control mechanism, and
retained. In this case, other amino acids at the same
position would lead to transport competent molecules.
To study both possibilities, a mutagenesis protocol
was designed that can result in several other amino
acids at position 1098 in the SI amino acid sequence
 .Q1098X . The transport compatibility of the mutants
in COS-1 cells was studied by immunoprecipitation
and immunofluorescence microscopy.
2. Materials and methods
2.1. Cell line
 .Monkey kidney COS cells ATCC CRL-1650
were maintained in Dulbecco’s modified Eagle’s
 .medium DMEM supplemented with 10% FCS and
 .antibiotics all from Gibco BRL Life Technologies .
Cells were cultured at 378C in a humidified 5% CO2
incubator.
2.2. Antibodies
Four epitope-specific monoclonal antibodies di-
rected against sucrase, isomaltase or sucrase–iso-
w xmaltase were used 16 . These antibodies were prod-
ucts of the following hybridomas: HBB 1r691r79,
HBB 2r614r88, HBB 2r219r20, HBB 3r705r60,
and will be referred to as HBB1r691, HBB2r614,
 .HBB2r219 and HBB3r705 resp. .
2.3. cDNA probes
For the substitution of Q1098 in the SI amino acid
sequence, a two-step PCR protocol was used. A
 .Bgl II fragment from position 2756 to 3377 of wild
type SI cDNA was subcloned into the Bgl II site of a
modified pGEM4 vector, resulting in the pSIBF con-
struct. The partially BglII-digested SI cDNA was
self-ligated, which resulted in the pSI DBgl. The
pSIBF construct was used as a template for the first
 XPCR reaction with 100 ng of SP6 primer 5 GATT-
X.TAGGTGACACTATAG3 and 100 ng of the degen-
 Xerate oligonucleotide SIMUT 5 CGATATT-
w xw xw xTGAATGAA ArT GrT CrT GTCATTAAA AG-
X.CAAA3 that is complementary to position 3281–
3313 of the SI cDNA, with the exception of the
nucleotides placed in brackets. The second PCR reac-
tion was performed using 12 pg of a 1850-bp Scal-
fragment of pSIBF and 20 ng of the 558-bp PCR-
product obtained from the previous amplification
round. Samples were taken after 5, 10, 15, 20 and 25
of the PCR protocol. The products of the second PCR
in the respective samples were amplified by PCR
 Xusing primers T7 5 TAATACGACTCACTA-
X.  .TAGGG3 and SP6 both 100 ng . The final 731 bp
products were isolated and digested with BglII,
cloned into a modified pGEM4 vector, and se-
quenced. Those inserts that were mutated at the
desired position and that did not contain any other
.mutations were digested with BglII, and cloned into
the BglII digested pSI DBgl vector, which resulted in
Q1098X mutant SI cDNA. Full-length wild-type and
Q1098X mutant SI cDNA, as well as the Q1098P
w xmutant 13 , were subcloned into the mammalian
w xexpression vector PSG5 17 .
pGEM4 and the SP6 and T7 primers were from
 .Promega Madison, USA . All PCR reactions were
performed using the following conditions: 5 ml 10=
 .PCR buffer Gibco BRL , 2 mM MgCl , 2.5 ml2
 .W1-detergent Gibco BRL , 250 mM dNTPs, two
 .units Taq polymerase Gibco BRL , primers and
template DNA in a final volume of 50 ml. The
mixture was incubated at 948C for 5 min, followed by
25 cycles of 1 min 948C, 1 min 458C, 1 min 728C.
After the last cycle and 10 min at 728C, the mixture
was stored at 48C.
2 .4 . T ra n s fec tio n , m e ta b o lic la b e lin g ,
immunoprecipitation and SDS-PAGE
COS-1 cells were transiently transfected via elec-
w xtroporation as described before 13 . Transfected cells
were washed once with methioninercysteine-free
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medium, and incubated in this medium for 1 h. After
35 this starvation period, 100 mCi Tran S label ICN
.Biomedicals was added to the medium. After the
labeling period followed by an optional chase period
.in normal medium , the cells were washed with PBS
and scraped in lysis buffer 1% Triton X-100, 0.2%
BSA in 100-mM phosphate buffer pH 8.0 containing
1 tablet complete protease inhibitor cocktail Boeh-
.ringer Mannheim, Almere, the Netherlands per 25
.ml and lysed at 48C for 1 h. Usually, 1-ml ice cold
lysis buffer was used for each 100-mm culture dish
 6 .about 2–4=10 cells . Lysates were stored at
y1358C until use. Detergent extracts of cells were
centrifuged for 1 h at 100,000=g at 48C and the
supernatants were immunoprecipitated as described
w xby Schweizer et al. 18 , using a mixture of the four
monoclonal antibodies against SI in a dilution of
1r1000 each.
SDS-PAGE was performed according to Laemmli
w x19 and the apparent molecular weights were as-
sessed by comparison with high molecular weight
 .markers Bio-Rad Laboratories run on the same gel.
2.5. Immunofluorescence
Cellular localization of expressed proteins in COS-
1 cells was studied with cells grown on coverslips.
Cells were fixed with 3% paraformaldehyde and per-
meabilized with 0.1% Triton X-100. Immunolabeling
was carried out using each of the four monoclonal
antibodies against SI separately as primary antibody
in a 1r1000 dilution. The secondary antibodies em-
ployed FITC-conjugated goat anti-mouse IgG Boeh-
.ringer . Label was visualized with a BioRad
MRC1000 confocal scanning laser microscope or on
a routine fluorescence microscope.
3. Results
3.1. Mutagenesis
To introduce mutations at amino acid 1098 of the
SI sequence, a PCR strategy was designed with a
degenerate oligonucleotide containing a triplet of
mismatches at position 3296 to 3298 of the SI cDNA.
 .This strategy for details, see Section 2 resulted in
two mutant SI cDNAs: Q1098A and Q1098K. The
constructs were expressed in COS-1 cells and the
transport compatibility of the mutants was assessed
by immunoprecipitation and immunolocalization
studies.
3.2. Immunoprecipitation
The processing of wild-type SI and the SI mutants
in COS-1 cells was studied by a pulse-chase labeling
experiment followed by immunoprecipitation of SI.
Fig. 2. Transfected COS-1 cells were metabolically labeled for 30 min and chased for 0, 4 and 24 h. After immunoprecipitation using a
mixture of the HBB 1r691, HBB 2r614, HBB 2r219 and HBB 3r705 monoclonal antibodies against SI, the precipitates were analyzed
on a 8% SDS-PAGE gel.
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After 30-min pulse and 0-h chase, only the high-man-
nose, 210 kDa band of both wild type SI and the
 .mutants is visible Fig. 2, lanes 1, 4, 7, 10 . The
complex glycosylated band of about 245 kDa appears
after 4 h of chase in the wild type, Q1098A and
Q1098K lanes. The high-mannose band has com-
pletely disappeared after 24 h of chase in lanes 3, 6,
and 9. In contrast, in the Q1098P lanes, there is no
complex glycosylated band visible after 4 or 24-h
 .chase Fig. 2, lane 11, 12 , after 24 h, there is no
band visible at all, the protein is completely de-
graded.
3.3. Immunofluorescence
The localization of wild type and mutant proteins
in COS-1 cells was assessed by immunofluorescence
using four monoclonal antibodies against SI. In Fig.
3, the localization of four proteins Q1098A, Q1098K,
.wtSI, Q1098P was determined in permeabilized cells.
Overall, it is visible that the localization of the
Q1098A and Q1098K mutants exactly matches the
pattern visible in the wild-type panels. All three
molecules can be found in an intracellular network
and at the cell surface. The Q1098P mutant however,
Fig. 3. Immunofluorescence microscopy on transfected COS-1 cells. Cells were grown on coverslips, fixed and labeled by four
 .monoclonal antibodies against SI with non-overlapping epitopes HBB1r691, HBB2r614, HBB2r219 and HBB3r705 , followed by
ITC-conjugated second antibodies.
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cannot be found at the cell surface, but only in an
intracellular network. This network was shown to
w xconsist of ER and cis-Golgi structures 14 .
The four monoclonal antibodies against SI have
epitopes that do not overlap, and some are maturation
dependent. It has previously been established that
HBB3r705 only has affinity for high-mannose gly-
w xcosylated SI 16 . Therefore, it is not surprising that it
only labels an intracellular network, probably the ER,
in all panels. HBB2r614 was shown to have equal
affinity for high-mannose and complex glycosylated
SI. Surface labeling and an intracellular network is
visible in wild type, Q1098A and Q1098K trans-
fected cells, whereas only the network can be seen in
Q1098P transfected cells.
In immunoprecipitation studies on Q1098P trans-
fected COS-cells, no protein could be precipitated
w xusing antibodies HBB2r219 and HBB1r691 14 .
The localization studies confirm these data; there
were no Q1098P transfected cells labeled by these
 .monoclonal antibodies see Fig. 3 . Cells transfected
with wild type, Q1098A and Q1098K SI were all
positive for both HBB1r691 and HBB2r219. Appar-
ently, the epitopes differ in maturation sensibility,
because HBB2r219 showed more affinity for an
intracellular perinuclear network, whereas HBB1r691
mainly labeled the cell surface. Studies using a mix-
ture of the four monoclonal antibodies on non-per-
meabilized cells revealed a strong surface labeling of
the wild type, Q1098A and Q1098K transfected cells.
A few of the Q1098P transfected cells showed a faint
labeling at their surface, but the majority was nega-
 .tive data not shown .
Overall, these results indicate that substitution of
glutamine at position 1098 by alanine or lysine does
not alter the transport compatibility of SI. Substitu-
tion by proline has more consequences in this regard,
w xas was shown before 13,14 .
4. Discussion
Amino acid substitutions can disturb the transport
of a protein along the secretory pathway. Previously,
we reported a glutamine for proline substitution at
 .position 1098 Q1098P that resulted in the accumu-
lation in the Golgi apparatus of the brush-border
enzyme sucrase–isomaltase in intestinal epithelial
cells from a patient with a phenotype II congenital
w xsucrase–isomaltase deficiency 13,14 . The substitu-
tion is present in a highly homologous region of the
protein, and results in a comparable accumulation
when introduced into the same region in a related
protein with another intracellular destination, lysoso-
w xmal a-glucosidase 14 . To study the importance of
the presence of a glutamine residue at position 1098
 .Q1098 , we analyzed the transport compatibility of
two mutants in which Q1098 is substituted by lysine
 .  .Q1098K or alanine Q1098A .
The pulse-chase experiments clearly show that both
Q1098A and Q1098K are processed at the same rate
as wild type sucrase–isomaltase, whereas the pro-
cessing of the Q1098P mutant is severely delayed.
The immunofluorescence data confirm this notion:
both Q1098A and Q1098K are expressed at the cell
surface, while the bulk of Q1098P accumulates intra-
cellularly due to overexpression, some cells did ex-
press a little of the Q1098P protein at the cell sur-
.face . Altogether, it can be concluded that both
Q1098A and Q1098K are fully transport competent.
The mutagenesis strategy was designed to generate
up to six different amino acids Lys, Ala, Asn, Thr,
.Glu, Asp at position 1098. Lysine and alanine were
the first two mutants from the pool of mutants that
were identified and analyzed. Because both these
mutants were fully transport-competent, we con-
cluded that the presence of glutamine at position
1098 is not essential for proper transport, therefore,
we did not undertake more efforts to analyze other
mutants.
To study gross structural alterations in the 3D
structure of sucrase–isomaltase, a panel of four mon-
oclonal antibodies was used that recognize different
non-overlapping epitopes in the protein. Some of
these epitopes are changed during processing. The
Q1098P mutant is not recognized by two of these
antibodies in the immunofluorescence localization
study. This could be a result of incomplete processing
by which the epitopes remain immature and are not
recognized. Alternatively, it can indeed be due to an
aberrant folding of the mutant, by which the epitopes
have disappeared. Due to this improper folding, the
mutant could be retained and finally degraded.
Proline is the amino acid that probably has the
largest influence on the 3D structure of a protein. It is
w xknown to introduce kinks in a-helices 20,21 . Fur-
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thermore, several mutant proteins have been reported
that lost their function andror transport properties
after introduction of a proline see for instance Refs.
w x.22–24 . Therefore, introduction of a proline at posi-
tion 1098 of sucrase–isomaltase has lead most likely
to alterations in the 3D structure of the protein that
are recognized by some kind of control mechanism,
and result in Golgi retention.
As a conclusion, although the glutamine at posi-
tion 1098 is highly conserved, it is not essential for
the transport compatibility of SI because substitution
of this residue by lysine or alanine does not affect
transport compatibility. We therefore conclude that
proline introduced a structural alteration that resulted
in retention in the Golgi apparatus and final degrada-
tion of the Q1098P mutant.
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